Sunday, November 3, 2024
24.4 C
Nairobi

Moderna halts construction of vaccine facility in Kenya

Moderna, a leading biotechnology company, has announced its decision to halt the construction of a vaccine manufacturing facility in Kenya.

This move comes as a result of the decreased demand for COVID-19 vaccines in the post-pandemic era.

The decision to pause the construction of the facility is part of Moderna’s larger strategy to resize its manufacturing network in order to reduce costs.

Moderna halts construction of vaccine facility in Kenya www.whoownsafrica.com
Moderna halts construction of vaccine facility in Kenya www.whoownsafrica.com

Despite this pause, the company is still committed to investing approximately $4.5 billion in research and development this year, focusing on the development of new vaccines for diseases such as cancer and respiratory syncytial virus (RSV).

Modern’s pipeline includes several mRNA vaccines, such as those for HIV and malaria, which are still in the early stages of development.

In light of this, the company has deemed it necessary to suspend its efforts to build an mRNA manufacturing facility in Kenya.

According to Moderna, this decision will enable the company to better align its infrastructure investments with the changing healthcare needs and vaccine demand in Africa.

By taking this strategic approach, Moderna aims to ensure that its resources are effectively allocated to meet the evolving needs of the region.

Moderna halts construction of vaccine facility in Kenya www.whoownsafrica.com
Moderna halts construction of vaccine facility in Kenya www.whoownsafrica.com

In 2022, the company announced a plan to invest $500 million in the Kenyan facility and supply up to 500 million doses of its mRNA vaccines to Africa annually. They planned to begin filling doses of their COVID vaccine on the continent as early as 2023.

Unfortunately, demand for COVID vaccines has decreased significantly since the end of the pandemic, leading to Moderna not receiving any vaccine orders from Africa since 2022.

The drugmaker has reported taking more than $1 billion in losses and write-downs due to the cancellation of previous orders from Africa. It is a stark reminder of the unpredictable nature of the pharmaceutical industry and the challenges companies face when trying to meet global health needs.


Discover more from Who Owns Africa

Subscribe to get the latest posts sent to your email.

Hot this week

Meet Uganda’s Hamis Kiggundu who’s richer than Ronaldo and Messi

Meet Uganda's Hamis Kiggundu, a name known for more...

Why Were Metal Masks Used During Slavery Time?

During the dark era of slavery, colonial masters implemented...

Timbuktu: The African city that was once the richest in the world

Timbuktu, located in the West African nation of Mali,...

How a Kenyan start-up is Harnessing Carbon Markets in Africa

In an innovative approach to revolutionising energy provision in...

Why BRICS Rejected Algeria’s Membership Bid

Algeria, a North African country rich in oil and...

Topics

Uganda sentences LRA commander Thomas Kwoyelo to 40 years for war crimes

A court in Uganda has sentenced Lord’s Resistance Army...

Mozambique ruling party declared winner of election amid fraud claims

Mozambique’s ruling party candidate, Daniel Chapo, has been declared...

Kenya secures $736 million power project deal with Adani

Kenya Electricity Transmission Company (Ketraco) and Adani Energy Solutions...

Nigeria: The Challenges and achievements of Tinubu administration

Nigerian President Bola Ahmed Tinubu Administration has been in...

Nigerian economy under radar of President Tinubu’s administration

As Nigeria marked 64 years of independence on 1st...

Kenya lawmakers vote to impeach Deputy President Gachagua

Lawmakers in Kenya have voted to impeach Deputy President...

How Congo rebels are raking in $300K every month from seized mining territory

Rebels operating in the eastern region of the Democratic...

Related Articles

Discover more from Who Owns Africa

Subscribe now to keep reading and get access to the full archive.

Continue reading